No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

0:00

Zakari Aliyu REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta ZAKARI ALIYU, Howard University, Washington DC Nigeria has the highest incidence of sickle cell anemi

Zakari Aliyu

Zakari Aliyu

REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, AtlantaZAKARI ALIYU, Howard University, Washington DCNigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with the disease. But a new study has shown that no one is using the standard therapy hydroxyurea to treat it. Derek Thorne got more fromZakari Aliyuof Howard University in Washington DC.

Related Episodes

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

Treatment of advanced pancreatic islet cell tumors with sunitinib has doubled progression-free survival in patients whose options have been very limited up to now, according to French researchers repo

Audio Journal of Oncology Volume 16 Number 11

Audio Journal of Oncology Volume 16 Number 11

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology

Blind For Blindness: Preventing Childhood Blindness

Blind For Blindness: Preventing Childhood Blindness

Hessom Razavi, Puneet Sayal, Claire Gilbert Hessom Razavi, Puneet Sayal, Claire Gilbert, London School of Hygiene and Tropical Medicine Eye doctor Hessom Razavi volunteered to go about his usual studi